PBMC of IS-treated AChR-MG patients showed significantly reduced spontaneous IFN-γ production as compared to those of non-treated AChR-MG patients (p = 0.003) and CON (p = 0.036, Fig 4A), suggesting that Th1 type immune responses were depressed by IS treatment. Here, IFNG is linked to myasthenia gravis.